Biogen Inc
BMV:BIIB

Watchlist Manager
Biogen Inc Logo
Biogen Inc
BMV:BIIB
Watchlist
Price: 3 125 MXN Market Closed
Market Cap: 24.3B MXN

Wall Street
Price Targets

BIIB Price Targets Summary
Biogen Inc

Wall Street analysts forecast BIIB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIIB is 3 314.87 MXN with a low forecast of 2 398.47 MXN and a high forecast of 4 986.92 MXN.

Lowest
Price Target
2 398.47 MXN
23% Downside
Average
Price Target
3 314.87 MXN
6% Upside
Highest
Price Target
4 986.92 MXN
60% Upside
Biogen Inc Competitors:
Price Targets
ADMA
ADMA Biologics Inc
43% Upside
KALV
Kalvista Pharmaceuticals Inc
122% Upside
SBTX
SkinBioTherapeutics PLC
53% Upside
ONCO
Oncopeptides AB
18% Upside
2480
Beijing Luzhu Biotechnology Co Ltd
37% Upside
ACE
Ascelia Pharma AB
160% Upside
ASND
Ascendis Pharma A/S
25% Upside
TECX
AVROBIO Inc
314% Upside

Revenue
Forecast

Revenue Estimate
Biogen Inc

For the last 13 years the compound annual growth rate for Biogen Inc's revenue is 5%. The projected CAGR for the next 4 years is 0%.

5%
Past Growth
0%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Biogen Inc

For the last 13 years the compound annual growth rate for Biogen Inc's operating income is 2%. The projected CAGR for the next 4 years is 4%.

2%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
Biogen Inc

For the last 13 years the compound annual growth rate for Biogen Inc's net income is 2%. The projected CAGR for the next 4 years is 11%.

2%
Past Growth
11%
Estimated Growth
Estimates Accuracy
19%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIIB's stock price target?
Price Target
3 314.87 MXN

According to Wall Street analysts, the average 1-year price target for BIIB is 3 314.87 MXN with a low forecast of 2 398.47 MXN and a high forecast of 4 986.92 MXN.

What is Biogen Inc's Revenue forecast?
Projected CAGR
0%

For the last 13 years the compound annual growth rate for Biogen Inc's revenue is 5%. The projected CAGR for the next 4 years is 0%.

What is Biogen Inc's Operating Income forecast?
Projected CAGR
4%

For the last 13 years the compound annual growth rate for Biogen Inc's operating income is 2%. The projected CAGR for the next 4 years is 4%.

What is Biogen Inc's Net Income forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for Biogen Inc's net income is 2%. The projected CAGR for the next 4 years is 11%.

Back to Top